Clinical Trial Update: Evaluation of Efficacy, Quality of Life and Cost Effectiveness of Short-course Radiotherapy Followed by Capecitabine Plus Oxaliplatin chemotheRapy and TME for High-risk Rectal Cancer (ESCORT Trial) [NA]

View source ↗

Summary

Clinical trial update on the ESCORT study evaluating efficacy, quality of life, and cost effectiveness of short-course radiotherapy followed by capecitabine plu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• Eloxatin (oxaliplatin)
• Xeloda (capecitabine)

Snippet

Sponsor: Yonsei University | Conditions: Locally Advanced Rectal Cancer | NA | Status: UNKNOWN